Dassault Systèmes’ 3DEXPERIENCE Platform Selected By Ion Beam Applications To Streamline Development Of Cancer Therapy Solutions

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

VELIZY-VILLACOUBLAY, France--(BUSINESS WIRE)--Dassault Systèmes (Euronext Paris: #13065, DSY.PA), the 3DEXPERIENCE Company, world leader in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, announced today that Ion Beam Applications SA (IBA), the leading medical device manufacturer and pioneer in proton beam therapy for cancer treatment, selected the 3DEXPERIENCE platform based on V6 architecture, and its “Licensed to Cure for Medical Device” industry solution experience. With “Licensed to Cure for Medical Device”, IBA will support the development processes of its medical accelerator solutions.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC